BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36513449)

  • 1. Soy isoflavones decrease fibroglandular breast tissue measured by magnetic resonance imaging in premenopausal women: A 2-year randomized double-blind placebo controlled clinical trial.
    Lu LW; Chen NW; Brunder DG; Nayeem F; Nagamani M; Nishino TK; Anderson KE; Khamapirad T
    Clin Nutr ESPEN; 2022 Dec; 52():158-168. PubMed ID: 36513449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.
    Nayeem F; Chen NW; Nagamani M; Anderson KE; Lu LW
    Nutr Res; 2019 Aug; 68():70-81. PubMed ID: 31421395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.
    Lu LW; Chen NW; Nayeem F; Ramanujam VS; Kuo YF; Brunder DG; Nagamani M; Anderson KE
    Clin Nutr; 2018 Dec; 37(6 Pt A):1862-1870. PubMed ID: 29183775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial.
    Lu LW; Chen NW; Nayeem F; Nagamani M; Anderson KE
    Eur J Nutr; 2020 Sep; 59(6):2369-2381. PubMed ID: 31535213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study.
    Tai TY; Tsai KS; Tu ST; Wu JS; Chang CI; Chen CL; Shaw NS; Peng HY; Wang SY; Wu CH
    Osteoporos Int; 2012 May; 23(5):1571-80. PubMed ID: 21901480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women.
    Nhan S; Anderson KE; Nagamani M; Grady JJ; Lu LJ
    Nutr Cancer; 2005; 53(1):73-81. PubMed ID: 16351509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.
    Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT;
    JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of soy isoflavones in normal human breast tissue.
    Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
    Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women.
    Lu LJ; Anderson KE; Grady JJ; Nagamani M
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3045-52. PubMed ID: 11443166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.
    Lu LJ; Cree M; Josyula S; Nagamani M; Grady JJ; Anderson KE
    Cancer Res; 2000 Mar; 60(5):1299-305. PubMed ID: 10728690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.
    Khan SA; Chatterton RT; Michel N; Bryk M; Lee O; Ivancic D; Heinz R; Zalles CM; Helenowski IB; Jovanovic BD; Franke AA; Bosland MC; Wang J; Hansen NM; Bethke KP; Dew A; Coomes M; Bergan RC
    Cancer Prev Res (Phila); 2012 Feb; 5(2):309-19. PubMed ID: 22307566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial.
    Wong WW; Lewis RD; Steinberg FM; Murray MJ; Cramer MA; Amato P; Young RL; Barnes S; Ellis KJ; Shypailo RJ; Fraley JK; Konzelmann KL; Fischer JG; Smith EO
    Am J Clin Nutr; 2009 Nov; 90(5):1433-9. PubMed ID: 19759166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
    Ho SC; Chen YM; Ho SS; Woo JL
    Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.
    Wu AH; Spicer D; Garcia A; Tseng CC; Hovanessian-Larsen L; Sheth P; Martin SE; Hawes D; Russell C; MacDonald H; Tripathy D; Su MY; Ursin G; Pike MC
    Cancer Prev Res (Phila); 2015 Oct; 8(10):942-51. PubMed ID: 26276750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year.
    Anderson JJ; Chen X; Boass A; Symons M; Kohlmeier M; Renner JB; Garner SC
    J Am Coll Nutr; 2002 Oct; 21(5):388-93. PubMed ID: 12356779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.
    Lu LJ; Anderson KE; Grady JJ; Kohen F; Nagamani M
    Cancer Res; 2000 Aug; 60(15):4112-21. PubMed ID: 10945618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women.
    Qin W; Zhu W; Shi H; Hewett JE; Ruhlen RL; MacDonald RS; Rottinghaus GE; Chen YC; Sauter ER
    Nutr Cancer; 2009; 61(2):238-44. PubMed ID: 19235040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake.
    Atkinson C; Skor HE; Fitzgibbons ED; Scholes D; Chen C; Wähälä K; Schwartz SM; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):253-60. PubMed ID: 11895874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial.
    Delmanto A; Nahas-Neto J; Traiman P; Uemura G; Pessoa EC; Nahas EA
    Menopause; 2013 Oct; 20(10):1049-54. PubMed ID: 23481125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.